NR3C1 and myeloid sarcoma: This confirms previous data of our lab and others, demonstrating a decreased expression of GR protein in CD8+ T cells of relapsing GC‐resistant as compared to relapsing GC‐sensitive patients with MS31 and a reduced level of GR protein in total peripheral blood mononuclear cells (PBMCs) of relapsing GC‐resistant patients with MS.32